Sterne, Kessler, Goldstein & Fox PLLC
Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell
The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides a soluble FZD receptor comprising an extracellular domain of a human FZD receptor that inhibits growth of tumor cells. The present invention still further provides a soluble receptor comprising a Fri domain of a human FZD receptor that binds a ligand of a human FZD receptor and said soluble receptor is capable of inhibiting tumor growth. The present invention still further provides a method of treating cancer comprising administering a soluble FZD receptor comprising for example, either an extracellular domain of a human FZD receptor or a Fri domain of a human FZD receptor, in an amount effective to inhibit tumor growth.
OncoMed Pharmaceuticals
A G C C C A A C C C A C G
A61K G01N C07K C07K C07K A61K A61K C07K C07K C07K A61P C07K G01N
additional inventional additional inventional additional inventional additional inventional inventional inventional inventional inventional inventional
Timothy Sanjeev John Austin
Hoey Satyal Lewicki Gurney